Development of the General Scale Observance for Chronic Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

397 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2017-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to assess the measurement characteristics (validity, reproducibility) and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease, by following the evolution of patient compliance at D0 and D15.

The second objective is to assess the sensitivity to change of scale EGOMAC following developments compliance 3 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

NCT05638269

Essential Hypertension Liver Cancer Nasopharyngeal Cancer +8 more

RECRUITING

LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions

NCT05293366

Long Covid-19

RECRUITING

Evaluation of the Vulnerable Carotid Atherosclerotic Plaque: A Clinical Multicenter Study

NCT05849909

Ultrasound

UNKNOWN

Associations of Age Measures With Serum Anti-Müllerian Hormone

NCT05297058

Aging

COMPLETED

Biomarkers of LONG COVID (LONG COVID_LCM)

NCT05672602

Long COVID

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During a routine appointment (D0), the patient filled a newsletter and a questionnaire to complete.

The doctor collects medical informations for the case report form.

At the end of the first consultation (D0), an additional EGOMAC scale and a stamped envelope is delivered to the patient by asking him to fill that scale to 15 days and return it by Post Office (reproducibility study).

Finally, a new scale will be addressed to the patient at the end of 3 months, which will return by Post Office too (stability study).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient age of 18 years
* from routine patient counseling
* with at least one of these diseases : heart failure, hypertension, coronary disease, type 2 diabetes, osteoarthritis of the knee or hip, osteoporosis, inflammatory rheumatism (rheumatoid arthritis, spondyloarthropathy), cancer ( with only non-hormonal oral anti cancer treatments) and HIV.
* patient can read the French language in order to complete the self -administered questionnaire
* patient agreeing to participate in the study

* patient receiving no drug prescription or recommendation of lifestyle or diet (for example consultationpurely diagnostic ).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No